How Iron Affects Cancer Cells' Response to Artesunate
Author Information
Author(s): Gerhard Kelter, Daniel Steinbach, Venkata Badireenath Konkimalla, Tsuyoshi Tahara, Shigeru Taketani, Heinz-Herbert Fiebig, Thomas Efferth
Primary Institution: Oncotest GmbH, Institute of Experimental Oncology, Freiburg, Germany
Hypothesis
Are transferrin receptor and ABC transporters involved in tumor cells' sensitivity to artesunate?
Conclusion
Ferrous iron can enhance the effectiveness of artesunate in some tumor cell lines, but not all.
Supporting Evidence
- High TfR expression correlates with better response to artesunate.
- ABCB6 expression increases with artesunate treatment.
- Iron can enhance the anti-cancer effects of artesunate in some cell lines.
Takeaway
Some cancer cells can be treated better with artesunate if they have more iron, but it doesn't work for every type of cancer cell.
Methodology
The study used a panel of 36 tumor cell lines treated with artesunate and iron to assess sensitivity and resistance.
Potential Biases
Potential bias in cell line selection and treatment response interpretation.
Limitations
The study may not account for all factors influencing tumor response to treatment.
Participant Demographics
The study involved various human tumor cell lines, including leukemia and breast cancer.
Statistical Information
P-Value
p=0.011 for TfR correlation
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website